Research Topics
| Bente Magny BergersenSummaryAffiliation: University of Oslo Country: Norway Publications
|
Detail Information
Publications
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjectsB M Bergersen
Department of Infectious Diseases, Ulleval University Hospital, 0407 Oslo, Norway
Eur J Clin Microbiol Infect Dis 23:625-30. 2004..In patients with elevated lipid levels, a change in the HAART regimen or treatment with lipid-lowering drugs should be considered...
Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipientsBente M Bergersen
Department of Infectious Diseases, Ulleval University Hospital, 0407 Oslo, Norway
Int J STD AIDS 16:365-9. 2005..40; 95% CI 1.47-7.86; P = 0.004) for low HDL-c level. Our study shows that NNRTI recipients have a more favourable HDL-c profile than PI recipients, even when possible confounding factors are taken into account...
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensiveB M Bergersen
Department of Infectious Diseases, Ulleval University Hospital, Oslo, Norway
HIV Med 6:260-7. 2005..To identify clinical factors associated with HIV-associated lipoatrophy and to evaluate body composition changes, blood pressure and lipid levels in lipoatrophic subjects 3-4 years after the atrophy diagnosis...
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controlsBente Magny Bergersen
Department of Infectious Diseases, Aker University Hospital, Oslo, Norway
Scand J Infect Dis 38:682-9. 2006..We conclude that fasting glucose, HDL-cholesterol, triglycerides and blood pressure should be closely monitored in all HAART-treated patients, not only in overweighed or lipodystrophic individuals...
Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapyBente Magny Bergersen
Department of Infectious Diseases, Aker University Hospital, Oslo, Norway
Drugs 66:1971-87. 2006..This review discusses important clinical aspects of treating middle-aged HIV-positive patients who have an increased risk of experiencing a cardiovascular event...
